As a standalone public company, Bausch now has the ability to freely allocate financial resources to innovate and develop businesses that were underfunded under its former parent company. We believe ...

Bausch Health turned down recent debt-restructuring proposals from bondholders as it explores a sale of its Bausch + Lomb vision care subsidiary that could bring in billions of dollars to pay ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Monday was an eventful day for Bausch + Lomb (NYSE: BLCO). The eye care specialist's major piece of internal news was that it earned its latest Food and Drug Administration (FDA) approval.

Private equity giants TPG and Blackstone have joined forces to submit a joint bid for eyecare company Bausch + Lomb, Financial Times reported citing sources familiar with the development. If ...

It isn't known whether Bausch + Lomb and/or Goldman is in contact with either Blackstone or TPG. According to the FT, several private equity funds mulling offers have dropped out of the race.

Bausch + Lomb shares surged Monday following reports Blackstone and TPG are considering teaming up to buy the eyecare company. A bid from Blackstone and TPG could reportedly value the company ...

Private equity players TPG and Blackstone are planning a joint bid for Canadian contact lens supplier Bausch + Lomb, Financial Times reported on October 14 citing people familiar with the matter.

Bausch + Lomb rises 12% in premarket trading after reports that Private equity groups TPG and Blackstone have teamed up to work on a joint bid for the eyecare company, according to the Financial Times ...

Bausch & Lomb (NYSE:BLCO) jumped 7.5% on a report that private equity firms TPG (TPG) and Blackstone (BX) are working on a joint bid for the eyecare company. Several other PE shops that have been ...

Bausch + Lomb is also in the process of seeking regulatory approvals for the lens in additional markets. Bausch + Lomb Corp announced the FDA has granted approval the enVista Envy full range of vision ...